The UN World Health Organization (WHO) has issued its first guideline on the use of a new class of weight-loss medicines, ...

Metagenomi, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary ...

UNITED NATIONS, Dec 01 (APP): The World Health Organization (WHO), a Geneva-based UN agency, has issued its first guideline on the use of a new class of weight-loss medicines, marking a significant ...

Tyra Biosciences, Inc. , a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) ...

B7H3 and PTK7 is co-expressed in multiple solid tumor types, including lung, colorectal, and head and neck cancers, at approximately 30%, 46%, and 27%, ...

The UN World Health Organization (WHO) has issued its first guideline on the use of a new class of weight-loss medicines, marking a significant ...

New analyses from the ongoing open label extension (OLE) studies and findings from electroencephalogram (EEG) assessments in ...

Based on Stoke Therapeutics’ preliminary estimates, which scaled annual incidence to prevalence using country-specific live birth rates over the past 85 years and adjusted for Dravet-specific ...

Recent advancements in artificial intelligence (AI) have revolutionized the application of electrocardiography (ECG) in ...

Researchers have used precision-engineered nanoparticles to clear toxic proteins from the brains of mice with ...

Long before humans wired their world with language, another kind of intelligence may have quietly mastered its own planet ...

Researchers at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust have developed AI software that automates the complex interpretation of whole-body diffusion-weighted MRI ...